• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.11% Nasdaq Up0.41%

    PDL BioPharma, Inc. (PDLI)

    3.22 Up 0.08(2.55%) 4:00PM EDT
    |After Hours : 3.22 0.00 (0.00%) 4:56PM EDT
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):3.0
    Mean Recommendation (last week):3.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:3.75
    Median Target:3.75
    High Target:4.00
    Low Target:3.50
    No. of Brokers:2

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jan 20, 2011RBC Capital MktsUpgradeSector PerformOutperform
    Sep 10, 2010RBC Capital MktsInitiated Sector Perform
    Mar 27, 2009Lazard Capital MktsUpgradeHoldBuy
    Jan 5, 2009JP MorganUpgradeUnderweightNeutral
    Sep 11, 2008JP MorganDowngradeNeutralUnderweight
    Jun 13, 2008Credit SuisseDowngradeOutperformNeutral
    Apr 22, 2008WachoviaDowngradeOutperformMkt Perform
    Mar 10, 2008Susquehanna FinancialDowngradePositiveNeutral
    Mar 5, 2008Broadpoint CapitalDowngradeBuyNeutral
    Mar 5, 2008Lehman BrothersDowngradeOverweightEqual-weight

    More Upgrades & Downgrades for PDLI

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0000

    Data provided by Thomson/First Call

    Currency in USD.